Advances in Inflammatory Biomarkers for Diabetic Retinopathy
Archives of Clinical Ophthalmology · 31.12.2025 · 4 (1) · 38
DOI: 10.33696/ophthalmology.4.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Clinical Ophthalmology, online erschienen am 31.12.2025. Verfasst von Honghong Dong und 1 weiteren Autor:innen. Die Arbeit nennt 66 Literaturangaben.
Abstract (Originalsprache)
Diabetic retinopathy is a leading cause of blindness in diabetic patients, and its onset and progression are influenced by inflammation. This article provides an overview of local inflammatory biomarker research in diabetic retinopathy, covering serum, aqueous humor, vitreous inflammatory factors, and retinal inflammation markers. Through a systematic review and analysis, we found that inflammatory biomarkers play a crucial role in the prediction, diagnosis, and treatment of diabetic retinopathy, as well as in understanding its pathological mechanisms and improving clinical diagnostic and therapeutic strategies. Future research should further investigate the role of inflammatory biomarkers in diabetic retinopathy to develop more effective strategies for early intervention and treatment of related diseases.
Zitieren
APA
Dong, H., & Ying (2025). Advances in Inflammatory Biomarkers for Diabetic Retinopathy. Archives of Clinical Ophthalmology, 4(1), 38. https://doi.org/10.33696/ophthalmology.4.020
Vancouver
Dong H, Ying. Advances in Inflammatory Biomarkers for Diabetic Retinopathy. Archives of Clinical Ophthalmology. 2025;4(1):38. doi:10.33696/ophthalmology.4.020
BibTeX
@article{Dong2025,
author = {Dong, Honghong and Ying},
title = {Advances in Inflammatory Biomarkers for Diabetic Retinopathy},
journal = {Archives of Clinical Ophthalmology},
year = {2025},
volume = {4},
number = {1},
pages = {38},
doi = {10.33696/ophthalmology.4.020}
}
EUVIMED